Representative Publications

View All Publications

Wang W, Erbe AK, Gallenberger M, Kim K, Carmichael L, Hess D, Mendonca EA, Song Y, Hank JA, Cheng SC, Signoretti S, Atkins M, Carlson A, Weiss JM, Mier J, Panka  D, McDermott DF, Sondel PM. Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2. Cancer immunology, immunotherapy : CII. 2016; 65(12):1523-1532. PubMed PMID: 27695964

Erbe AK, Wang W, Goldberg J, Gallenberger M, Kim K, Carmichael L, Hess D, Mendonca EA, Song Y, Hank JA, Cheng SC, Signoretti S, Atkins M, Carlson A, Mier JW, Panka DJ, McDermott DF, Sondel PM. FCGR Polymorphisms Influence Response to IL-2 in Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016; PubMed PMID: 27742794

Horta ZP, Goldberg JL, Sondel PM. Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy. Immunotherapy. 2016; 8(9):1097-117. PubMed PMID: 27485082

Wang W, Erbe AK, Alderson KA, Phillips E, Gallenberger M, Gan J, Campana D, Hank  JA, Sondel PM. Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion. Cancer immunology, immunotherapy : CII. 2016; 65(9):1047-59. PubMed PMID: 27392940

Albertini MR, Ranheim EA, Zuleger CL, Sondel PM, Hank JA, Bridges A, Newton MA, McFarland T, Collins J, Clements E, Henry MB, Neuman HB, Weber S, Whalen G, Galili U. Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma. Cancer immunology, immunotherapy : CII. 2016; 65(8):897-907. PubMed PMID: 27207605, PMCID: PMC4958541                             

Morris ZS, Guy EI, Francis DM, Gressett MM, Werner LR, Carmichael LL, Yang RK, Armstrong EA, Huang S, Navid F, Gillies SD, Korman A, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM. In Situ Tumor Vaccination by Combining Local Radiation and  Tumor-Specific Antibody or Immunocytokine Treatments. Cancer research. 2016; 76(13):3929-41. PubMed PMID: 27197149, PMCID: PMC4930687

Neri D, Sondel PM. Immunocytokines for cancer treatment: past, present and future. Current opinion in immunology. 2016; 40:96-102. PubMed PMID: 27060634

Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L, Levy R, Lyerly HK, Maecker H, Marabelle A, Melenhorst J, Miller J, Melero I, Odunsi K, Palucka K, Peoples G, Ribas A, Robins H, Robinson W, Serafini T, Sondel P, Vivier E, Weber J, Wolchok J, Zitvogel L, Disis ML, Cheever MA. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. Journal for immunotherapy of cancer. 2016; 4:15. PubMed PMID: 26981245, PMCID: PMC4791805

Erbe AK, Wang W, Gallenberger M, Hank JA, Sondel PM. Genotyping Single Nucleotide Polymorphisms and Copy Number Variability of the FCGRs Expressed on NK Cells. Methods in molecular biology (Clifton, N.J.). 2016; 1441:43-56. PubMed PMID: 27177655

Jensen JL, Rakhmilevich A, Heninger E, Broman AT, Hope C, Phan F, Miyamoto S, Maroulakou I, Callander N, Hematti P, Chesi M, Bergsagel PL, Sondel P, Asimakopoulos F. Tumoricidal Effects of Macrophage-Activating Immunotherapy in a  Murine Model of Relapsed/Refractory Multiple Myeloma. Cancer immunology research. 2015; 3(8):881-90. PubMed PMID: 25941352, PMCID: PMC4527950

Goldberg JL, Sondel PM. Enhancing Cancer Immunotherapy Via Activation of Innate Immunity. Seminars in oncology. 2015; 42(4):562-72. PubMed PMID: 26320061, PMCID: PMC4555881

Shi Y, Felder MA, Sondel PM, Rakhmilevich AL. Synergy of anti-CD40, CpG and MPL in activation of mouse macrophages. Molecular immunology. 2015; 66(2):208-15. PubMed PMID: 25829245, PMCID: PMC4461517

Wang W, Erbe AK, Hank JA, Morris ZS, Sondel PM. NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy. Frontiers in immunology. 2015; 6:368. PubMed PMID: 26284063, PMCID: PMC4515552

McDowell KA, Hank JA, DeSantes KB, Capitini CM, Otto M, Sondel PM. NK cell-based  immunotherapies in Pediatric Oncology. Journal of pediatric hematology/oncology.  2015; 37(2):79-93. PubMed PMID: 25590232, PMCID: PMC4429888

Methods in Molecular Biology Erbe AK, Wang W, Gallenberger M, Hank JA, Sondel PM. Somanchi S, editor. Berlin, Gemmany: Springer Press; 2015. Genotyping Single Nucleotide Polymorphisms and Copy Number Variability of the FcγRs expressed on NK cell